Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

COLIPA UV Simulator Standards Sought For FDA Sunscreen Reg - Petition

This article was originally published in The Tan Sheet

Executive Summary

The OTC sunscreen monograph should be amended to include the adoption of the European Cosmetic, Toiletry & Perfumery Association's standard for solar simulators used in sunscreen testing, Rapid Precision Labs states in a June 29 citizen petition. Solar simulators mimic the spectral risk of natural sunlight and are used to ascertain the efficacy of sunscreen products.

You may also be interested in...



Additional High SPF Sunscreen Data Sought By FDA

FDA expects to publish a "comprehensive" sunscreen final monograph covering formulation, labeling and testing methodologies for both UVA and UVB radiation by Dec. 31, 2001, the agency announces in a June 8 Federal Register notice.

Additional High SPF Sunscreen Data Sought By FDA

FDA expects to publish a "comprehensive" sunscreen final monograph covering formulation, labeling and testing methodologies for both UVA and UVB radiation by Dec. 31, 2001, the agency announces in a June 8 Federal Register notice.

Additional High SPF Sunscreen Data Sought By FDA

FDA expects to publish a "comprehensive" sunscreen final monograph covering formulation, labeling and testing methodologies for both UVA and UVB radiation by Dec. 31, 2001, the agency announces in a June 8 Federal Register notice.

Related Content

Topics

UsernamePublicRestriction

Register

PS090009

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel